Surgery – Means for introducing or removing material from body for... – Treating material introduced into or removed from body...
Patent
1994-06-23
1997-10-28
McDermott, Corrine M.
Surgery
Means for introducing or removing material from body for...
Treating material introduced into or removed from body...
604 53, 604 21, 6048901, 128898, A61M 3100
Patent
active
056812787
ABSTRACT:
Method and apparatus for treating blood vessels in a mammal, particularly humans, especially coronary blood vessels, for vascular thrombosis and angioplasty restenosis, thereby to decrease incidence of vessel rethrombosis, unstable angina and myocardial infarction, by administering a conager of an endothelium-derived bioactive agent, especially a nitrovasodilator, including one or more of nitric oxide or a nitric oxide donor agent, such as sodium nitroprusside and nitroglycerin, to an extravascular treatment site at a therapeutically effective dosage rate.
REFERENCES:
patent: 3923060 (1975-12-01), Ellinwood
patent: 4003379 (1977-01-01), Ellinwood
patent: 4346227 (1982-08-01), Terahara
patent: 5069662 (1991-12-01), Bodden
patent: 5075108 (1991-12-01), McKenzie
patent: 5100392 (1992-03-01), Orth
patent: 5140012 (1992-08-01), McGovern
patent: 5167960 (1992-12-01), Ito
patent: 5212165 (1993-05-01), Aberg
patent: 5222936 (1993-06-01), Stephen
patent: 5236413 (1993-08-01), Feiring
patent: 5298018 (1994-03-01), Narcisco
patent: 5304120 (1994-04-01), Crandell
patent: 5403834 (1995-04-01), Malfroy-Camine et al.
patent: 5405919 (1995-04-01), Keefer
"Role of blood platelets and prostaglandins in coronary artery disease", Mehta J. et al., Amer. J. Cardiol., 48:366, 1981.
"Hemodynamic effects of prostaglandin E.sub.1 infusion in patients with acute myocardial infarction and left ventricular failure": Popat K. et al., Amer. Heart J., 103:485, 1982.
"The interaction of sodium nitroprusside with human endothelial cells and platelets: Nitroprusside and prostacyclin synergistically inhibit platelet function", Levin R. et al., Circ., 66:1299, 1982.
"Prostaglandins and cardiovascular disease: A review", Jacobsen D., Surgery, 93:564, 1983.
"Cellular proliferation in atherosclerosis and hypertension", Schwartz S. et al., Prog. Cardiovasc. Dis., 26:355, 1984.
"Prostaglandin E.sub.1 inhibits DNA synthesis in arterial smooth muscle cells stimulated with platelet-derived growth factors", Nilsson J. et al., Atherosclerosis, 53:77, 1984.
"Mechanisms contributing to precipitation of unstable angina and acute myocardial infarction: Implications regarding therapy", Epstein S. et al., Amer. J. Cardiol., 54:1245, 1984.
"Unstable angina with fatal outcome: Dynamic coronary thrombosis leading to infarction and/or sudden death", Falk E., Circ., 71:699, 1985.
"The pathogenesis of atherosclerosis: An update", Ross R. ., N. Engl. J. Med, 314:488, 1986.
"Speculation regarding mechanisms responsible for acute ischemic heart disease syndromes", Willerson J. et al., J. Amer. Col. Cardiol., 8:245, 1986.
"Comparison of equimolar concentrations of iloprost, prostacyclin, and prostaglandin E.sub.1 on human platelet function", Fisher C et al., J. Lab. Clin. Med., 109: 184, 1987.
"Prostaglandin E.sub.1 infusion after angioplasty in humans inhibits abrupt occlusion and early restenosis", See J. et al., Adv. Prostaglandin, Thromboxane and Leukotriene Res., 17:266, 1987.
"Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor", Palmer R. et al., Nature, 327:524, 1987.
"Role of platelets and thrombosis in mechanisms of acute occlusion and restenosis after angioplasty", Harker L., Amer. J. Cardiol., 60: 20B, 1987.
"The antiaggregating properties of vascular endothelium: Interactions between prostacyclin and nitric oxide", Radomski M. et al., Brit. J. Pharmacol., 92: 639, 1987.
"Local anticoagulation without systemic effect using a polymer heparin delivery system", Okada T. et al., Stroke, 19:1470, 1988.
"Intrapericardial instillation of platin in malignant pericardial effusion", Fiorentino M. et al., Cancer, 62:1904, 1988.
"Is vasospasm related to platelet deposition?", Lam J. et al., Circ., 75:243, 1988.
"Platelets, vasoconstriction, and nitroglycerin during arterial wall injury: A new antithrombotic role for an old drug", Lam J. et al., Circ., 78:7122, 1988.
"Human endothelial cells inhibit platelet aggregation by separately stimulating platelet cAMP and cGMP", Alheid U. et al., Europ. J. Pharmacol., 164:103, 1989.
"Localized release of perivascular heparin inhibits intimal proliferation after endothelial injury without systemic anticoagulation", Okada T. et al., Neurosurgery, 25:892, 1989.
"Effect of platelet factors on migration of cultured bovine aortic endothelial and smooth muscle cells", Bell L. et al., Circ. Res., 65:1057, 1989.
"EDRF increases cyclic GMP in platelets during passage through the coronary vascular bed", Pohl U. et al., Circ. RES., 65:1798, 1989.
"Restenosis after coronary angioplasty: Potential biologic determinants and role of intimal hyperplasia", Liu M. et al., Circ., 79:1374, 1989.
"Nitric oxide generating vasodilators and 8-Br-cGMP inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells", Garg U. et al., J. Clin. Invest., 83:1774, 1989.
"Role of platelets in smooth muscle cell proliferation and migration after vascular injury in rat carotid artery", Fingerle J. et al., Proc. Natl. Acad. Sci., 86:8412, 1989.
"Use of streptokinase to aid drainage of postoperative pericardial effusion", Cross J. et al., Brit. Heart J., 62:217, 1989.
"Syndromes of accelerated atherosclerosis: Role of vascular injury and smooth muscle cell proliferation", Ip J. et al., J. Amer. Col. Cardiol., 15:1667, 1990.
"Effect of short-term prostacyclin administration on restenosis after percutaneous transluminal coronary angioplasty", Knudtson M. et al., J. Amer. Col. Cardiol., 15:691, 1990.
"Platelets and thrombolytic therapy", Coller B. ., N. Engl. J. Med, 322:33, 1990.
"Regulatory functions of the vascular endothelium", Vane J. et al., N. Engl. J. Med., 323:27, 1990.
"Control of coronary vascular tone by nitric oxide", Kelm M. et al., Circ. Res., 66:1561, 1990.
"Time course of smooth muscle cell proliferation in the intima and media of arteries following experimental angioplasty", Hanke H. et al., Circ. Res., 67:651, 1990.
"Effect of controlled adventitial heparin delivery on smooth muscle proliferation following endothelial injury", Edelman E. et al., Proc. Natl. Acad. Sci., 87:3773, 1990.
"Nitric oxide and prostacyclin: Divergence of inhibitory effects on monocyte chemotaxis and adhesion to endothelium in vitro", Bath P. et al., Arterioscler. Thromb., 11:254, 1991.
"Direct intraarterial wall injection of microparticles via a catheter: A potential drug delivery strategy following angioplasty", Wilensky R. et al., Amer. Heart J., 122: 1136, 1991.
"Prevention of restenosis after percutaneous transluminal coronary angioplasty: The search for a `magic bullet`", Hermans W. et al., Amer. Heart J., 122:171, 1991.
"Endothelial modulation of vascular tone: Relevance to coronary angioplasty and restenosis", Harrison D. , J. Amer. Col. Cardiol., 17:71B, 1991.
"The role of platelets thrombin and hyperplasia in restenosis after coronary angioplasty", Ip J. et al., J. Amer. Col. Cardiol, 17:77B., 1991.
"Intravenous nitroglycerin infusion inhibits cyclic blood flow responses caused by periodic platelet thrombus formation in stenosed canine coronary arteries", Folts J. et al., Circ., 83:2122, 1991.
"Clinical trials of restenosis after coronary angioplasty", Popma J. et al., Circ., 84:1426, 1991.
"Frequency and severity of cyclic flow alterations and platelet aggregation predict the severity of neointimal proliferation following experimental coronary stenosis and endothelial injury", Willerson J. et al., Proc. Natl. Acad. Sci., 88:10624, 1991.
"Nitric oxide: An endogenous modulator of leukocyte adhesion", Kubes P. et al., Proc. Natl. Acad. Sci., 88:4651, 1991.
"The restenosis paradigm revisited: An alternative proposal for cellular mechanisms", Schwartz R. et at., J. Amer. Col. Cardiol., 20:1284, 1992.
"Metabolic activation of sodium nitroprusside to nitric oxide in vascular smooth muscle", Kowaluk E. et al., J. Pharmacol. Exper. Therapeutics, 262:916, 1992.
"The pathogenesis of coronary artery disease and the acute coronary syndromes: Parts I and II", Fuster V. et al., N. Engl. J. Med., 326:242 and 310, 1992.
"Iontophoretic transmyocardial drug delivery: A novel approach to an
Igo Stephen R.
Meador James W.
Burgess Tim L.
Cormedics Corp.
McDermott Corrine M.
Smith Chalin
LandOfFree
Coronary vasculature treatment method does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Coronary vasculature treatment method, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Coronary vasculature treatment method will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1022496